Latest news with #PrecedenceStatistics
Yahoo
08-04-2025
- Health
- Yahoo
Chronic Obstructive Pulmonary Disease Market Size Expected to Surge USD 34.76 Bn by 2034
The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to reach around USD 34.76 billion by 2034, growing at a CAGR of 4.42% for the forecasted period. Ottawa, April 08, 2025 (GLOBE NEWSWIRE) -- The global chronic obstructive pulmonary disease market size was valued at USD 22.55 billion in 2024 and is predicted to hit around USD 33.29 billion by 2033, a study published by Towards Healthcare a sister firm of Precedence Statistics. Get All the Details in Our Solutions – Download Brochure: Market Overview Chronic obstructive pulmonary disease (COPD) is a respiratory disorder mainly caused by long-term exposure to smoke, fumes, dust, and chemicals. It causes inflammation of the airways that limits airflow into and out of the lungs. Emphysema and chronic bronchitis are two types of COPD. Pulmonary function tests, imaging, and lab tests are techniques to diagnose COPD. COPD is usually treated using bronchodilators, steroids, phosphodiesterase-4 inhibitors, and antibiotics. The rising prevalence of COPD and increasing air pollution drive the market. Advancements in diagnostics and growing research and development activities lead to the early diagnosis of COPD. It also results in the development of novel drugs and drug delivery systems for the effective treatment of COPD. Numerous government organizations support the diagnosis and treatment of COPD. Moreover, technological advancements drive the latest innovations, augmenting market growth. Chronic Obstructive Pulmonary Disease Market Trends Rising Prevalence of COPD: COPD is the fourth leading cause of death globally. The increasing geriatric population and tobacco smoking are some of the major causes of COPD. According to a recent systemic review and meta-analysis report published in BMC Public Health, the prevalence of COPD in people over 40 years is 12.64%. Growing Research and Development Activities: Numerous researchers identify the potential biomarkers and targets responsible for disease progression. This enables them to develop novel asthma and COPD drugs and drug delivery systems for targeted drug delivery with enhanced efficacy and reduced side effects. Advanced testing kits are also developed for the early detection of COPD. Demand for Personalized Treatment: Personalized medicine approaches focus on understanding an individual's disease risk and tailoring management. The growing demand for personalized treatment expedites the development of gene and stem cell therapy. Personalized lung disease therapeutics offer a promising approach for COPD patients in the near future. Favorable Government Support: Several government organizations create awareness about the screening and early diagnosis of COPD. They also provide funding for conducting research and providing treatment. You can place an order or ask any questions, please feel free to contact us at sales@ Limitations & Challenges in the Chronic Obstructive Pulmonary Disease Market Limited Accessibility: People from developing and underserved areas or low- and middle-income countries are more prone to developing COPD. Most COPD deaths occur in people living in these areas due to a lack of appropriate diagnostic tools and treatment regimens. They are also unaware about screening of COPD. High Cost: The treatment cost of COPD is relatively higher, limiting the affordability for people from low- and middle-income groups. It is estimated that direct national medical costs specific to COPD may increase to $60.5 billion by 2029. The maintenance therapy for COPD also poses a significant economic burden on patients. Smart Inhalers: The Future of COPD Treatment The advent of advanced technologies such as artificial intelligence (AI) and machine learning (ML) has led to the development of smart inhalers. Smart inhalers are built with AI-enabled sensors that help record data about the time, location, and date of use. AI monitors and delivers the accurate dose to patients. Connecting smart inhalers with smartphone apps provides patients with automatic reminders for their next dose. The device can also alert the patients if they forget to carry it with them. Some devices also indicate the appropriate usage of inhalers and the strength of breathing. Moreover, smart inhalers provide real-time data to healthcare professionals, enabling remote monitoring of patients. There are currently 7 FDA-approved smart inhalers available on the market. Apart from smart inhalers, researchers are also developing smart nebulizer devices to automate the flow and depth of each inhalation. For instance, In April 2024, Adherium announced U.S. FDA approval of Hailie Smartinhaler, a high-tech device that can monitor medication use and compliance. The device can be used with AstraZeneca's Airsupra and Breztri inhalers. Get the latest insights on healthcare industry segmentation with our Annual Membership: Regional Analysis Favorable Government Policies Dominated North America North America dominated the global chronic obstructive pulmonary disease market in 2024. Advanced healthcare infrastructure and favorable reimbursement policies facilitate the latest treatment for COPD patients. State-of-the-art research and development facilities lead to the development of innovative diagnostic and treatment regimens for COPD. Favorable government policies and regulatory framework govern market growth in North America. Another major factor is the growing awareness about chronic health conditions, including COPD, favoring early diagnosis and treatment. Countries Contributing to Market Growth United States: The rising prevalence of COPD is a major concern among people in the U.S. According to the American Lung Association, COPD affects around 16 million people in America. Around 8% of people living in rural communities and 5% of people living in urban communities suffer from COPD. Canada: The Canadian government formed the 'National Lung Health Framework' to prevent and manage respiratory diseases among Canadian people. The Lung Health Foundation anticipated that COPD would be a $10 billion healthcare crisis in Canada by 2030. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes—schedule a call today: Growing Awareness to Promote Asia-Pacific Asia-Pacific is anticipated to grow at the fastest rate in the chronic obstructive pulmonary disease market during the forecast period. The increasing geriatric population and air pollution in developing nations are the major risk factors of COPD in the region. The increasing healthcare expenditure and sedentary lifestyles contribute to market growth. Numerous government and private organizations conduct symposiums, conferences, and workshops to create awareness about COPD management. The increasing investments, collaborations, and mergers & acquisitions also promote the market. Countries like China, India, and Japan are at the forefront of the booming market in Asia-Pacific. China: The Chinese government is making constant efforts to increase the accessibility of early diagnosis and treatment of COPD. The government has launched key initiatives to screen people at high risk of COPD and a national program for improving the use of lung function tests. India: In October 2024, doctors from New Delhi reported a 30-40% surge in respiratory diseases like asthma and COPD owing to the rising air pollution. The region reported an air quality index of 317. Japan: The Japanese government launched the 'Health Japan 21' initiative in 2024 to reduce the death rate from COPD. The goal of the initiative is to reduce the death rate from COPD per 100,000 people from 13.3 in 2021 to 10.0 by 2032. Customize this study as per your requirement @ Segment Outlook Disease Insights The chronic bronchitis segment held a dominant presence in the chronic obstructive pulmonary disease market in 2024. Chronic bronchitis refers to the inflammation of the bronchial tubes. The rising prevalence and severity of chronic bronchitis boost the segment's growth. Chronic bronchitis affects around 27% to 35% of all COPD patients. It results in a frequent cough with mucus. The major reason for chronic bronchitis is smoking. Globally, around four adults smoke tobacco. Additionally, the increasing prevalence of gastroesophageal reflux and the growing geriatric population fuel the segment's growth. Treatment Insights The drugs segment held the largest share of the chronic obstructive pulmonary disease market in 2024. Drugs for treating COPD include short- and long-acting bronchodilators, steroids, phosphodiesterase-4 inhibitors, theophylline, mucolytics, and antibiotics. These respiratory drugs mainly act by suppressing the symptoms of COPD rather than treating the root cause of the disease. Hence, growing research and development activities and technological advancements favor the development of novel drugs. The growing awareness of combination therapy augments the segment's growth. Combination drugs improve the patient's condition by reducing bronchoconstriction through more than one mechanism. The increasing demand for generic alternatives provides a cost-effective option for patients with COPD. The oxygen therapy segment is expected to grow at the fastest rate in the chronic obstructive pulmonary disease market during the forecast period. COPD patients need supplemental oxygen as there isn't enough oxygen in the blood, and they have difficulty breathing. The increasing COPD exacerbations necessitate the use of oxygen therapy. COPD patients require an oxygen saturation range of 88-92%. The availability of portable devices favors the segment's growth. Portable devices are especially beneficial for the geriatric population, eliminating the need to visit any healthcare setting. Numerous clinical trial study oxygen therapy in COPD patients. There are 42 recruiting and active, not recruiting clinical trials registered on website studying oxygen therapy in COPD patients, as of March 2025. End-User Insights The hospitals & clinics segment led the global chronic obstructive pulmonary disease market in 2024. The segmental growth is attributed to the presence of skilled professionals, favorable infrastructure, and suitable capital investment. This leads to the increased adoption of advanced equipment for monitoring and treating COPD. The increasing incidences of acute exacerbations of COPD also foster the segment's growth. The availability of favorable reimbursement policies, both government and private, potentiates the number of hospitalizations. Some hospitals and clinics are also part of clinical trials assessing the potential of novel drugs and devices on COPD patients. This enables patients to be a part of the trial and benefit from the novel products before market approval. Recent Breakthroughs in the Chronic Obstructive Pulmonary Disease Market In April 2025, TidalSense, a respiratory diagnostic technology company, announced the launch of N-Tidal Diagnose, an AI tool for diagnosing COPD. The AI tool could automatically interpret the CO2 waveform output from a patient's normal breathing pattern and accurately diagnose COPD within 5 minutes. The device is set to roll out across the NHS from 14th April 2025. In May 2024, Verona Pharma announced the launch of ensifentrine in the third quarter of 2024. Ensifentrine is a first-in-class phosphodiesterase 3/4 inhibitor for reducing the exacerbations of COPD. The drug received U.S. FDA approval after two positive results from its Phase 3 clinical trials (ENHANCE-1 and ENHANCE-2). Browse More Insights of Towards Healthcare: Chronic Lower Back Pain Market Size: Vitrification Market Size: Antibody Drug Conjugate Market Size: Microbial Fermentation Technology Market Size: Biomaterials Market Size: Retinal Biologics Market Size: U.S. Cell Therapy Market Size: Catheter Related Bloodstream Infection Market Size: Human Chorionic Gonadotropin Market Size: Cannabis Vaporizer Market Size: Cell Therapy Market Size: Cell Therapy Human Raw Materials Market: Biobanking Market Size: Cell Signaling Market: Spine Biologics Market Size: Segments Covered in the Report By Disease Chronic Bronchitis Emphysema By Treatment Drugs Bronchodilator Monotherapy Short-acting Beta2 Agonists (SABAs) Long-acting Beta2 Agonists (LABAs) Anti-inflammatory Drugs Oral & Inhaled Corticosteroids Anti-leukotrienes Oxygen Therapy Surgery Lung Volume Reduction Surgery (LVRS) Lung Transplant Bullectomy Others By End-User Hospitals & Clinics Homecare Settings Others By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Discover our detailed Table of Contents (TOC) for the Chronic Obstructive Pulmonary Disease (COPD) Market @ For pricing details and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us: in to access your portfolio
Yahoo
08-04-2025
- Automotive
- Yahoo
Automotive 3D Printing Market Size to Lead USD 16.01 Bn by 2034
The global automotive 3d printing market size is calculated at USD 6.10 billion in 2025 and is expected to reach around USD 16.01 billion by 2034, growing at a CAGR of 19.40% from 2025 to 2034. Ottawa, April 08, 2025 (GLOBE NEWSWIRE) -- The global automotive 3d printing market size was valued at USD 5.00 billion in 2024 and is predicted to hit around USD 16.01 billion by 2034, a study published by Towards Automotive a sister firm of Precedence Statistics. Get All the Details in Our Solutions – Download Brochure: Market Overview The automotive 3D printing market is experiencing significant growth due to the rising adoption of additive manufacturing to enhance efficiency, customization, and cost-effectiveness. 3D printing technology is revolutionizing automotive fabrication by facilitating rapid prototyping, tooling, and even the manufacturing of end-use components. Car manufacturers are utilizing this technology to create lightweight, complex, and high-performance parts, which are particularly advantageous for electric and high-performance cars. The capacity to generate intricate designs while minimizing material waste is accelerating widespread implementation among both OEMs and aftermarket suppliers. Additive manufacturing enables producers to fabricate parts that meet specific customer requirements. This feature is especially advantageous for luxury and high-performance automobiles, where consumers often look for distinctive qualities. The incorporation of AI and machine learning is further refining 3D printing methods, enhancing design accuracy and speeding up production times. Moreover, developments in multi-material printing are enabling the production of strong and functional components, broadening the use of 3D printing from prototyping to full-scale manufacturing. The shift toward sustainable and on-demand production is also contributing to market growth, as 3D printing reduces material waste and energy usage. Government programs supporting additive manufacturing and increased investments from major automotive companies are propelling market expansion. As automotive firms continue to explore new opportunities with 3D printing, the market is anticipated to grow swiftly, providing innovative manufacturing, customization, and supply chain efficiency solutions within the automotive industry. You can place an order or ask any questions, please feel free to contact us at sales@ Major Trends in the Automotive 3D Printing Market Growth of Metal 3D Printing for Final Parts: Automotive producers are adopting metal 3D printing to create lightweight and robust components. Techniques such as direct metal laser sintering and electron beam melting make it possible to fabricate complex metal parts, enhancing vehicle performance and efficiency. Integration of AI and Automation: Integrating AI algorithms in 3D printing improves accuracy, minimizes mistakes, and optimizes material utilization. Automated systems are streamlining the additive manufacturing workflow, facilitating quicker prototyping and large-scale production while reducing the need for human involvement. Increase in Multi-Material Printing: Innovations in multi-material 3D printing allow for the creation of parts with different properties, such as both flexible and rigid areas within the same component. This trend is especially useful for manufacturing functional items such as interior panels, seals, and customized vehicle parts. Rising Use in Electric Vehicle Production: 3D printing significantly contributes to electric vehicle production by lowering vehicle weight and enhancing electric vehicle battery efficiency. Manufacturers are employing additive manufacturing to create lightweight parts, tailored battery enclosures, and aerodynamic structures to boost EV performance and range. Limitations & Challenges in the Automotive 3D Printing Market High Initial Investment Requirements: Implementing 3D printing in the automotive field requires substantial investments in cutting-edge printers, materials, and software. Smaller and mid-sized manufacturers may struggle to manage these expenses, limiting widespread adoption. Limitations in Material and Quality Concerns: Despite advancements in 3D printing materials, there still exist limitations regarding strength, durability, and heat resistance, particularly for metal and composite components. Maintaining consistent quality and adhering to automotive industry standards continues to be a challenge. Slow Production Rates for Mass Manufacturing: Although 3D printing excels in prototyping and low-volume production, it is generally slower than traditional manufacturing techniques like injection molding and CNC machining. Scaling 3D printing for mass production within the automotive sector presents a significant obstacle. Get the latest insights on automotive industry segmentation with our Annual Membership: Demand for Customized Automotive Parts: Market's Largest Potential The rising demand for customized and on-demand production of spare parts creates immense opportunities in the automotive 3D printing market. Conventional supply chain methods necessitate substantial inventories and comprehensive logistics systems, which lead to high storage expenses and possible delays. Through 3D printing, manufacturers can create customized or discontinued spare parts as needed, decreasing reliance on centralized production sites. The production of lightweight vehicles presents another substantial opportunity. As automakers pursue improved fuel efficiency and sustainability, components made from advanced polymers and composites that are 3D-printed can greatly improve vehicle performance while minimizing emissions. Additionally, the rising production of electric vehicles intensifies the need for innovative 3D-printed battery housing, cooling systems, and structural parts. With the expansion of the EV market, 3D printing will be pivotal in enhancing vehicle efficiency, sustainability, and design versatility, signifying a transformative change in automotive manufacturing. Regional Analysis What to Expect from North American Countries till 2030? North America dominated the automotive 3D printing market with the largest share in 2024 due to its robust industrial foundation, technological innovations, and early adoption of additive manufacturing within the automotive industry. The presence of prominent automakers such as Ford, General Motors, and Tesla, as well as major 3D printing firms such as Stratasys and 3D Systems, has fostered a strong innovation ecosystem. The region's significant investment in research and development, paired with the rising demand for lightweight, fuel-efficient, and customized automotive parts, has further propelled market growth. Governmental initiatives that support advanced manufacturing and sustainability have facilitated widespread adoption. North America's intense focus on electric vehicles, autonomous driving, and digital manufacturing has established it as a leader in automotive 3D printing. The incorporation of artificial intelligence, the Internet of Things, and automation into additive manufacturing processes has improved production efficiency, lowering costs and reducing time-to-market for automotive parts. Top North American Countries that have Stronghold on the Automotive 3D Printing Market United States: The U.S. stands as the largest market, propelled by major automakers such as Ford, General Motors, and Tesla, along with prominent 3D printing firms like Stratasys and 3D Systems. The country benefits from substantial R&D investments, government backing for advanced manufacturing, and a strong emphasis on electric vehicles and autonomous driving technologies. Canada: Canada is emerging as a significant contender in the automotive 3D printing sector, supported by government-funded projects and an expanding network of automotive R&D hubs. The nation is progressively adopting 3D printing for lightweight vehicle components and sustainable manufacturing practices, especially in the electric vehicle domain. Mexico: Mexico is becoming prominent player in the automotive 3D printing market due to its robust automotive manufacturing sector, low production costs, and growing embrace of additive manufacturing technologies. Major global automotive firms operating in Mexico are utilizing 3D printing for prototyping, tooling, and small-scale production, enhancing the country's presence in the market. Asia Pacific to Boom Rapidly: Innovation in the Market to Support the Growth Asia Pacific is expected to witness the fastest growth during the forecast period. This rapid growth can be attributed to increasing investments in cutting-edge manufacturing technologies, a surge in demand for electric and autonomous vehicles, and government initiatives that encourage industrial automation. Leading nations such as China, Japan, and South Korea are paving the way, with their strong automotive sectors incorporating 3D printing for tasks like prototyping, producing lightweight components, and enabling mass customization. Elevate your automotive strategy with Towards Automotive. Enhance efficiency and drive better outcomes—schedule a call today: Major Factors for the Market's Expansion in Asia Pacific: Asia Pacific includes some of the largest automobile manufacturers, such as those in China, Japan, and South Korea. The growing production of electric and autonomous vehicles is driving the adoption of 3D printing to optimize manufacturing processes and decrease expenses. Numerous governments in the region are supporting industrial automation and advanced manufacturing through funding and policy advantages. Initiatives like "Made in China 2025" and Japan's emphasis on smart manufacturing are speeding up the adoption of 3D printing in the automotive industry. The region is observing considerable investments in research and development focused on additive manufacturing. Companies and institutions are making advancements in material science, printing speed, and precision, which are increasing the feasibility of 3D printing for large-scale automotive endeavors. The existence of major market players and research institutions driving innovation supports the automotive 3D printing market in the region. As the largest automotive market in the world, China is making substantial investments in 3D printing technologies to enhance production efficiency and minimize costs. Japan, recognized for its precision engineering in the automotive field, is utilizing additive manufacturing to improve production efficiency and cut waste. South Korea is integrating 3D printing into the development of next-generation vehicles, backed by its advanced technology sector. Moreover, India and Southeast Asian countries are emerging as potential markets, benefiting from rising automotive production and government policies that favor digital manufacturing. As automotive manufacturers increasingly adopt 3D printing within their supply chains, Asia Pacific is set to lead the market, presenting significant opportunities for industry players aiming to expand their presence. Segment Outlook Offering Insights The hardware segment dominated the automotive 3D printing market with the largest share in 2024. This segment encompasses 3D printers, print heads, and other essential components for additive manufacturing. The rising need for high-speed, precise, and cost-effective 3D printing machines has prompted adoption by automotive manufacturers and suppliers. The availability of sophisticated hardware compatible with diverse materials, combined with ongoing innovations from key players, has enhanced performance and reliability in the hardware segment. Additionally, the incorporation of IoT and AI into 3D printing hardware has boosted automation and efficiency, further cementing this segment's position at the forefront. The service segment is expected to expand at a notable CAGR during the forecast period. This expansion is driven by an increasing demand for design, prototyping, consulting, and maintenance services provided by both OEMs and third-party suppliers. Many automotive companies are turning to service bureaus for their 3D printing needs to avoid the hefty initial costs associated with equipment and materials. Furthermore, as new users join the market, the dependence on expert services for customized solutions, design improvements, and part performance evaluations is projected to rise. The shift toward subscription-based service models is also contributing to long-term growth in this segment. Type Insights The stereolithography (SLA) segment led the automotive 3D printing market in 2024. SLA is widely utilized due to its capability to create exceptionally accurate and detailed prototypes with smooth finishes, making it suitable for both interior and functional part prototyping. It plays a crucial role in the early design and validation phases of automotive production. Automakers prefer SLA for its precision, swift turnaround, and versatility with materials. Furthermore, advancements in resin formulations and quicker curing techniques have enhanced the efficiency and scalability of stereolithography across various automotive applications, ensuring it retains its leading position. The selective laser sintering (SLS) segment is projected to grow at the fastest rate during the projection period. This method involves using laser bim to fuse powdered materials, creating durable and intricate shapes without the need for support structures. Automotive firms are increasingly adopting SLS for the production of functional parts, jigs, and fixtures, particularly for under-the-hood and structural uses. The rising acceptance of SLS for both prototyping and small-batch production, along with the introduction of new high-performance materials, is significantly boosting its integration throughout the automotive manufacturing sector. Material Insights The polymers segment dominated the automotive 3D printing market in 2024. Lightweight, adaptable, and cost-efficient polymers are widely utilized for prototyping, fabricating interior components, and some under-the-hood applications. Materials such as ABS, PLA, and nylon lead the market due to their user-friendliness and compatibility with various 3D printing technologies. The increasing demand for polymer 3D printing is also driven by its capacity to produce intricate and custom shapes, thereby minimizing material waste and reducing tooling expenses. The automotive industry's emphasis on weight reduction to enhance fuel efficiency has further accelerated the use of polymer-based 3D printed parts. The metal 3D printing segment is likely to grow at a rapid pace in the coming years. Metals like aluminum, titanium, and stainless steel are becoming increasingly valued for crafting robust, durable, and heat-resistant automotive components. Applications span from engine parts and brake systems to custom structural elements in high-performance and luxury vehicles. As technology evolves, metal 3D printing is shifting from a focus on prototyping to the manufacturing of end-use parts. Progressions in powder bed fusion and directed energy deposition are making metal printing more cost-efficient and scalable, propelling its use for both performance improvements and mass customization. Component Insights The interior components segment dominated the automotive 3D printing market with the largest share in 2024. Car manufacturers are progressively employing 3D printing to produce dashboard components, control panels, air vents, and trim elements due to its design versatility and customization options. This method enables manufacturers to meet diverse customer preferences without incurring significant tooling expenses. The capacity to quickly create low-volume, intricate interior parts supports accelerated vehicle development cycles and fosters greater design innovation. As consumer demands for tailored interiors and premium finishes rise, 3D printing has become a favored approach for producing high-quality interior automotive elements. The exterior components segment is expected to grow at a significant rate during the forecast period. The increasing demand for aerodynamic parts, body panels, bumpers, and grilles that can be rapidly prototyped or manufactured in small runs has driven the application of 3D printing in this area. Advanced materials, including reinforced polymers and metal composites, facilitate the creation of durable and weather-resistant exterior components. Additionally, advancements in 3D printing capabilities into large-format production have unlocked new possibilities for full-scale exterior parts, accelerating their adoption in concept vehicles and specialized productions. Application Insights The prototyping segment dominated the market in 2024. This is mainly due to the rise in the demand for rapid prototyping to accelerate production cycles. Additive manufacturing facilitates quick design iteration and testing of vehicle components prior to final production. This approach significantly lowers lead times and development expenses, enabling manufacturers to expedite market launches. Automotive research and development teams utilize 3D printing for assessing form, fit, and function, leading to enhanced design validation and performance evaluation. As the automotive industry remains committed to innovation and efficiency in product development, prototyping through 3D printing is a fundamental application of additive manufacturing worldwide. The production segment is anticipated to expand at a notable CAGR during the forecast period. This trend is fueled by the rising adoption of additive manufacturing for producing low-volume, tailored, and high-performance automotive components. As 3D printing technologies become more economically viable and materials advance, manufacturers are tapping into its capabilities for creating end-use parts, especially for electric vehicles, motorsports, and luxury automobiles. The capacity to manufacture intricate components without traditional tooling minimizes waste, accelerates production timelines, and enables real-time adjustments in manufacturing. This evolution transforms conventional automotive production methodologies and accelerates this segment's growth. Recent Breakthroughs in the Global Automotive 3D Printing Market: In March 2024, Stratasys Ltd. acquired the technology portfolio and intellectual property from Arevo, Inc., a Silicon Valley-based firm that specializes in direct digital additive manufacturing with composite materials. This acquisition encompasses key patents related to carbon fiber printing, enhancements in Z-strength, AI-driven in-situ build monitoring, and hardware design. By incorporating this technology into Stratasys' FDM printing systems, the company aims to broaden its manufacturing capabilities and deliver parts with superior performance, more dependable builds, and improved system efficiency. In March 2024, EOS GmbH introduced the EOS M 290 1kW, a new Laser Powder Bed Fusion (LPBF) metal additive manufacturing platform aimed at serial production. The EOS M 290 1kW is suitable for a variety of industries, including automotive, and provides a wide array of validated materials and processes. This platform is designed to enhance design versatility, reduce weight, and improve cost-effectiveness in metal additive manufacturing. Browse More Insights of Towards Automotive: 3D Printing in Aerospace and Defense Market: Automotive 3D Map System Market: Automotive Disc Brake Market: Autonomous Ships Market: Marine Port Services Market: Motorsport Market: HD Maps for Autonomous Vehicles Market: Polyurethane-Based Foams in Automotive Market: PP Compound Automotive Market: Used Cars Market: Segments Covered in the Report By Offering Hardware Extrusion System Motion System Build Platform Environs Control And Monitoring System Software Design Software Inspection Software Printer Software Scanning Software Services By Type Stereolithography (SLA) Selective Laser Sintering (SLS) Fused Deposition Modeling (FDM) Electron Beam Melting (EBM) Digital Light Processing (DLP) Others By Material Metal Polymer Ceramic By Component Interior Component Exterior Component By Application Prototyping Tooling Production Others Acquire our comprehensive analysis today @ You can place an order or ask any questions, please feel free to contact us at sales@ Subscribe to our Annual Membership and gain access to the latest insights and statistics in the automotive industry. Stay updated on automotive industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the competition with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of automotive: Get a Subscription About Us Towards Automotive is a premier research firm specializing in the automotive industry. Our experienced team provides comprehensive reports on market trends, technology, and consumer behaviour. We offer tailored research services for global corporations and start-ups, helping them navigate the complex automotive landscape. With a focus on accuracy and integrity, we empower clients with data-driven insights to make informed decisions and stay competitive. Join us on this revolutionary journey as we work together as a strategic partner to reinvent your success in this ever-changing automotive world. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Healthcare | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us: in to access your portfolio
Yahoo
25-02-2025
- Business
- Yahoo
Water and Wastewater Treatment Market Size to Worth USD 652.30 Bn by 2034 with a 6.5% CAGR
The global water and wastewater treatment market size is expected to be worth over USD 652.30 billion by 2034 and is accelerating a solid CAGR of 6.50% between 2025 and 2034. Ottawa, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The water and wastewater treatment market size is calculated at USD 369.60 billion in 2025. It is forecasted to hit around USD 652.30 billion by 2034 increasing from USD 347.90 billion in 2024, a study published by Precedence Research a sister firm of Precedence Statistics. The worldwide market is growing significantly with a compound annual growth rate of 6.50% (2025-2034) due to the growing need for clean water for various purposes, especially drinking. This Report is Readily Available for Immediate Delivery | Download the Sample Pages of this Report@ Water and Wastewater Treatment Market Key Takeaways Asia Pacific dominated the global market with the largest market share of 36.10% in 2024. The membrane separation segment held a major market share of 34.77% in 2024. The tertiary segment contributed the biggest market share of 43.73% in 2024. The industrial segment accounted for the highest market share of 66.03% in 2024. The water and wastewater treatment market has grown and changed significantly on a worldwide scale in recent years. The technologies and solutions in this market are diverse and are intended to treat and purify water for use in commercial, industrial, and municipal settings. The need for effective wastewater management and clean water has grown globally due to factors including industrialization, urbanization, and population expansion. Water and wastewater treatment technologies have become more popular as a result of strict government laws and environmental concerns. The sector has also undergone a transformation thanks to the introduction of cutting-edge technologies like digitization, remote monitoring, and smart water management systems, which provide real-time data analysis, increased efficiency, and cost-effectiveness. For questions or customization requests, please reach out to us @ sales@ | +1 804 441 9344 Growth Factors in the Water and Wastewater Treatment Market Increased water scarcity: water and wastewater treatment is highly essential due to the growing water scarcity of drinkable and usable water. Without the treatment plants, water will not be treated for use again for different purposes. Rising population: Every year, the population rises significantly, which has led to the growing demand for water for drinking, household purposes, and other purposes. In the future, as the population grows, more and more water will be needed to fulfill the growing demand. Rising industrialization: almost every industry requires water for different procedures. Industrialization has led to a vast amount of water consumption. As industrialization grows, the demand for water also increases. The rise in agriculture: A large population requires a large amount of food, due to which a very big portion of water is used in agriculture. With the rise in technologies like hydroponics and vertical farming, the consumption of water has increased even further. Opportunities in the Water and Wastewater Treatment Market In January 2025, in order to help the Regional Water Company Prishtina improve sewage treatment through the construction of two wastewater treatment plants and network expansion, the European Bank for Reconstruction and Development (EBRD) is offering Kosovo's Ministry of Finance, Labor, and Transfers a sovereign loan of up to €25 million. In December 2024, with the completion of its most recent funding round, VVater, a next-generation water treatment company dedicated to providing sustainable, clean water access solutions, announced that it had received substantial support from well-known investors, including venture capitalist Tim Draper, Dick Anderson of HPI, and two other well-known billionaire investors. In March 2024, with a total budget of US$10.5 million, the Global Green Growth Institute (GGGI) and the Department of Planning (DoP) of the Ministry of Planning and Investment (MPI) of Lao PDR, with funding from the Korea International Cooperation Agency (KOICA), have started a project called "Scaling Out Sustainable Solid Waste and Wastewater Management to Improve Public Health and Environment in Lao PDR." Water And Wastewater Treatment Market Report Coverage Report Coverage Details CAGR 2025-2034 6.50 % Market Size in 2024 USD 347.90 Billion Market Size in 2025 USD 369.60 Billion Market Size by 2034 USD 652.30 Billion Forecast Period 2025 to 2034 Base Year 2024 Segments Covered Equipment, Process, Application, and Regions Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Browse Our Subscription Plans@ Asia Pacific Water and Wastewater Treatment Market Size to Hit USD 282.80 Bn by 2034 The Asia Pacific water and wastewater treatment market size was valued at USD 125.60 billion in 2024 and is expected to hit approximately USD 282.80 billion by 2034. The APAC market is projected to grow at a notable CAGR of 8.60% from 2024 to 2034. Asia Pacific Water and Wastewater Treatment Market holds a significant share of 36.10% in 2024. Rising Industrialization is Driving the Asia Pacific Asia Pacific held the largest share of the water and wastewater treatment market in 2024. There is a significant need for water and wastewater treatment solutions due to the fast urbanization, industrialization, and population increase in nations like China, India, and Southeast Asia. The area is seeing large expenditures in the construction of infrastructure, government programs aimed at protecting the environment and conserving water, and a growing understanding of the significance of sustainable water management techniques. The Asia Pacific water and wastewater treatment market is expanding due to the rise in industrial activity, the requirement to comply with strict regulations, and the need to enhance the quality of the water. In April 2024, Watertech China 2024, the largest one-stop global water treatment sourcing event, offers possibilities to progress enterprises in China and across the world for organizations who are leading the way in innovative solutions or eager to use the most recent technology advancements in water treatments. Watertech China 2024 is expected to transform the sector with the introduction of at least 300 new goods and services from well-known international firms. The largest worldwide sourcing event in the water treatment sector, the event is anticipated to draw an amazing 100,000 attendees and has an extensive roster of over 2,500 exhibitors. India has water scarcity in several areas while having 18% of the world's population and only 4% of its water resources. India has launched a number of national programs to improve public health and the environment while also expanding basic infrastructure. For instance, in March 2023, India is to invest about US$240 billion in the nation's water industry, according to Minister Jal Shakti Gajendra Singh Shekhawat, who made the announcement during the UN 2023 Water Conference. In addition, it is working to restore groundwater levels and is executing the biggest dam restoration operation in the world. Stringent Regulations is Driving North America North America is estimated to host a significantly growing water and wastewater treatment market during the forecast period. The area is known for its sophisticated infrastructure, strict environmental laws, and great awareness of water conservation and quality. The need to update outdated water infrastructure, deal with water shortage challenges, and guarantee regulatory compliance are some of the drivers driving the need for water and wastewater treatment systems in North America. The dominance of North America in the industry is further influenced by the existence of established market players, technical developments, and large R&D expenditures. Wastewater treatment is one of the most popular methods of pollution control in the US. The nation has an extensive network of treatment facilities, pumping stations, and collection sewers. Sewers transport wastewater from residences, workplaces, and other industries to treatment facilities. In the U.S., there are more than 16,000 publicly owned water resource recovery facilities. To guarantee that modern and new facilities continue to safeguard the environment and public health, knowledgeable engineers and operators collaborate. Water and Wastewater Treatment Market Segmentation AnalysisBy Equipment AnalysisThe membrane separation segment held the largest share of the water and wastewater treatment market in 2024. Pollutants, microorganisms, and harmful microbes may all be efficiently captured using membrane separation technology. High quality, stability, and safety are its benefits over traditional water treatment methods. The advancement of membrane separation technology has even been dubbed "the third industrial revolution" by experts. The biological segment is estimated to grow at the fastest rate during the forecast period. Biological treatment is a contemporary method that uses microorganisms rather than chemicals to clean wastewater. Numerous biological wastewater treatment methods, including membrane bioreactors, trickling filters, and the traditional activated sludge process, can be utilized to eliminate a range of contaminants from wastewater. By Process Analysis The tertiary segment dominated the water and wastewater treatment market in 2024. A third, more complex, and demanding degree of therapy is added with tertiary care. Water that has undergone tertiary treatment can be sufficiently purified to be used again in water-intensive operations or even as drinking water. The secondary segment is expected to achieve the fastest CAGR during the forecast period. After the main phase, the secondary treatment phase further filters the water to eliminate more trash, making it an essential step in the wastewater treatment process. By Application Analysis The industrial segment gained the majority shares of the water and wastewater treatment market in 2024. Tons of water are used daily by industries for manufacturing and other purposes. The methods and systems used to treat water for industrial usage are known as industrial wastewater treatment solutions. By decreasing water usage and boosting water availability, water treatment in enterprises may contribute to sustainability. One of the main benefits of water treatment in industries is cost reduction. Browse Related Reports: The global water treatment chemicals market size is worth around USD 34.54 billion in 2024 and is anticipated to reach around USD 49.15 billion by 2034, growing at a CAGR of 3.59% over the forecast period from 2024 to 2034. The global pharmaceutical water market size accounted for USD 42.95 billion in 2024, grew to USD 47.47 billion in 2025 and is projected to surpass around USD 99.30 billion by 2034, representing a healthy CAGR of 8.55% between 2025 and 2034. The global produced water treatment market size was estimated at USD 8.82 billion in 2024 and is predicted to increase from USD 9.51 billion in 2025 to approximately USD 18.58 billion by 2034, expanding at a CAGR of 7.73% from 2025 to 2034. The global wastewater treatment chemicals market size is calculated at USD 37.35 billion in 2024 and is predicted to hit around USD 54.76 billion by 2034, expanding at a CAGR of 3.90% from 2024 to 2034. The global point-of-use water treatment systems market size is worth around USD 34.51 billion in 2024 and is anticipated to reach around USD 83.21 billion by 2034, growing at a CAGR of 9.2% over the forecast period from 2024 to 2034. The global water storage systems market size is worth around USD 21.32 billion in 2024 and is anticipated to reach around USD 19.81 billion by 2034, growing at a CAGR of 7.62% over the forecast period 2024 to 2034. The global liquid waste management market size was calculated at USD 100.31 billion in 2024 and is predicted to increase from USD 102.82 billion in 2025 to approximately USD 128.29 billion by 2034, expanding at a CAGR of 2.49% from 2025 to 2034. The global bottled water market size accounted for USD 335.5 billion in 2024, and it is expected to hit around USD 565.23 billion by 2034, poised to grow at a CAGR of 5.35% from 2025 to 2034. The global water soluble fertilizer market size accounted for USD 16.07 billion in 2024 and is expected to be worth around USD 26.28 billion by 2034, at a CAGR of 5% from 2024 to 2034. The global liquid waste management market size was calculated at USD 100.31 billion in 2024 and is predicted to increase from USD 102.82 billion in 2025 to approximately USD 128.29 billion by 2034, expanding at a CAGR of 2.49% from 2025 to 2034. Water and Wastewater Treatment Market Key Players Suez Environnement S.A. (France) Veolia Environnement SA. (France) Xylem, Inc. (U.S.) DuPont de Nemours, Inc. (U.S.) 3M Company, Inc. (U.S.) Pentair plc (U.K.) United Utilities Group PLC (U.K.) Kingspan Group Plc (U.K.) The Dow Chemical Company (U.S.) BASF SE (Germany) Kurita Water Industries Ltd. (Japan) Bio-Microbics, Inc. (U.S.) Calgon Carbon Corporation (U.S.) Trojan Technologies Inc. (Canada) Kemira Oyj (Finland) Thermax Limited (India) Wog Technologies (India) Golder Associates, Inc. (Canada) SWA Water Technologies PTY LTD. (Australia) Burns & McDonnell (U.S.) Adroit Associates Private Limited (India) Sauber Environmental Solutions Pvt. Ltd. (India) SPEC Limited (India), Ecolab, Inc. (U.S.) GFL Environmental Inc. (U.S.) Clean TeQ Water Limited (Australia) What is Going Around the Globe? In September 2024, more than $100 million was secured for the Water and Climate Resilience fund by WaterEquity, an asset manager specializing in funding water and sanitation solutions in frontier and emerging markets. In January 2024, in a Series A investment headed by early-stage venture fund Mela Ventures and cleantech firm Emerald Technology Ventures, located in Zurich, smart water treatment solutions company INDRA raised $4 million. The Climate Angels and Peak Sustainability Ventures also participated in the financing. In January 2024, about €5 million was invested in Membion, a company established in Roetgen, by TechVision Fonds (TVF) and DeepTech & Climate Fonds (DTCF). The firm creates and manufactures wastewater treatment membrane bioreactor (MBR) modules. The research report categorizes the Water and Wastewater Treatment Market into the following segments and subsegments: By Equipment Membrane Separation Biological Disinfection Sludge Treatment Others By Process Primary Secondary Tertiary By Application Municipal Industrial By Region North America Europe Asia-Pacific Latin America Middle East & Africa (MEA) Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or Asia Pacific. Immediate Delivery Available | Buy This Premium Research Report@ You can place an order or ask any questions, please feel free to contact at sales@ | +1 804 441 9344 Precedence Research offers exclusive subscription services designed to provide in-depth data and analytics insights. With a subscription, you gain access to a comprehensive suite of statistical resources, market intelligence, and research tools tailored to your business needs. Whether you're looking for industry trends, competitive analysis, or future market projections, our subscription plans ensure you stay ahead with reliable, up-to-date information. Browse Our Subscription Plans@ About Us Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. Web: Our Blogs: Towards Healthcare | Towards Packaging | Statifacts | Towards EV Solutions | Towards Dental | Towards Automotive | Nova One Advisor Get Recent News: For Latest Update Follow Us: LinkedIn | Facebook | TwitterSign in to access your portfolio
Yahoo
24-02-2025
- Business
- Yahoo
U.S. Artificial Intelligence in Diagnostics Market Size to Surpass USD 4.29 Billion by 2034
The U.S. artificial intelligence in diagnostics market size is calculated at USD 790.59 million in 2025 and is expected to reach around USD 4.29 billion by 2034, growing at a CAGR of 20.7% for the forecasted period. Ottawa , Feb. 24, 2025 (GLOBE NEWSWIRE) -- The U.S. artificial intelligence in diagnostics market size was valued at USD 655 million in 2024 and is expected to surpass around USD 4.29 billion by 2034, growing at a compound annual growth rate (CAGR) of 20.7% over the forecast period 2025 to 2034, a study published by Statifacts a sister firm of Precedence Statistics. U.S. Artificial Intelligence In Diagnostics Market Report Highlights By component, the software segment dominated the U.S. artificial intelligence in diagnostics market in 2024 and accounted for the highest revenue share, and the segment is also expected to be the fastest growing during the forecast period. By diagnosis type, the neurology diagnosis type segment led the U.S. artificial intelligence in diagnostics market in 2024 with the largest revenue share. By diagnosis type, the radiology diagnosis type segment is expected to grow at the fastest rate during the forecast period. Elevate your business strategy with Statifacts. Improve efficiency and achieve better outcomes—schedule a consultation today! The Rising government initiatives and support are estimated to drive the growth of U.S. artificial intelligence in the diagnostics market. The key players operating in the market are focused on adopting inorganic growth strategies like mergers and partnerships to develop advanced-level machinery integrated with artificial intelligence for diagnosis purposes, which has been estimated to drive the growth of the U.S. artificial intelligence in diagnostics market. The rising prevalence of chronic diseases has increased the demand for accurate diagnosis solutions, which is estimated to drive the U.S. artificial intelligence in diagnostics market over the forecast period. The increasing incidence of chronic and non-communicable diseases (NCDs) necessitates advanced diagnostic solutions. AI enhances early detection and personalized treatment plans, improving patient outcomes and reducing healthcare costs. Chronic diseases like cancer, diabetes, and cardiovascular conditions require early detection for effective management. AI-powered diagnostic tools enhance accuracy, speed up detection, and reduce misdiagnosis risks. AI can analyze vast amounts of medical data (such as imaging scans, lab reports, and electronic health records) more efficiently than traditional methods, improving diagnostic precision and personalized treatment plans. AI-driven diagnostic tools, including wearable devices and telemedicine solutions, enable early detection and disease monitoring, particularly for chronic disease patients in remote areas. A shortage of medical professionals is estimated to drive the growth of the market in the near future. The U.S. faces a shortage of radiologists and pathologists, leading to increased adoption of AI to fill these gaps. AI technologies can process large datasets, identify patterns, and generate insights, thereby improving diagnostic accuracy and efficiency. The International Council of Nurses (ICN) issued a study in March 2023 urging that the U.S. nursing shortage be handled as a U.S. health emergency. The report, Recover to Rebuild: Investing in the Nursing Workforce for Health System Effectiveness, describes how the pandemic affected access to care, nurse burnout, and the U.S. nursing workforce. The authors argue that investing in and safeguarding nurses is essential to the rehabilitation of the healthcare sector. U.S. Artificial Intelligence In Diagnostics Market Report Scope Report attribute Details Market size value in 2025 USD 790.59 Million Revenue forecast in 2034 USD 4.29 Billion Growth rate CAGR of 20.7% from 2025 to 2034 Base year for estimation 2024 Historical data 2019 - 2024 Forecast period 2023 - 2034 Quantitative units Revenue in USD million/billion and CAGR from 2023 to 2034 Report coverage Revenue, company ranking, competitive landscape, growth factors, and trends Segments covered Component, diagnosis type, region Key companies profiled Aidoc; AliveCor, Inc.; Vuni, Inc.; Digital Diagnostics, Inc.; Siemens Healthineers; Neural Analytics; Riverain Technologies; Zebra Medical Vision, Inc; GE Healthcare; Imagen Technologies Technological advancements in AI are estimated to drive the growth of the U.S. artificial intelligence in diagnostics market in the near future. Continuous improvements in AI algorithms and machine learning enhance data processing capabilities, enabling more accurate and timely diagnostics. AI's ability to analyze complex datasets and identify patterns contributes to better patient outcomes and operational efficiency. AI-integrated diagnostic tools allow remote analysis of medical images and data, expanding access to healthcare in rural and underserved areas. AI chatbots and virtual assistants provide preliminary assessments, improving patient engagement. AI assists radiologists, pathologists, and other specialists by handling repetitive diagnostic tasks, easing their workload. AI-driven decision support tools help doctors make informed decisions faster, improving patient outcomes. AI ensures compliance with healthcare regulations by monitoring and analyzing medical records for inconsistencies. AI-powered cybersecurity solutions protect sensitive patient data from cyber threats and breaches. Increased investment and funding are estimated to drive the growth of the market in the near future. Significant funding from both private and public sectors is accelerating the development of AI-enhanced diagnostic tools. Demand for cost reduction and improved patient care has been estimated to drive the growth of the U.S. artificial intelligence in diagnostics market. Healthcare providers are increasingly adopting AI-driven diagnostics to reduce costs associated with diagnostic errors and inefficiencies. AI aids in early disease detection and personalized treatment plans, leading to improved patient care and reduced healthcare expenditures. Immediate Delivery Available | Buy This Premium Databook ( Price USD 1550 ) U.S. Artificial Intelligence in Diagnostics Market Trends Enhanced & Improved Diagnostic Tools: AI integration is improving the accuracy and efficiency of diagnostic processes, particularly in medical imaging and pathology. For instance, AI-assisted mammography is being explored to enhance breast cancer detection, especially in dense breast tissues. Need for Human Oversight: Despite AI's potential to reduce healthcare costs, its effective implementation requires significant human support to maintain performance and accuracy, highlighting the necessity for continuous oversight and resource allocation. Mitigating Specialist Shortages: AI technologies are being developed to alleviate the U.S. shortage of pathologists by increasing diagnostic speed and accuracy, thereby enhancing productivity and patient care. U.S. Artificial Intelligence in Diagnostics Market Top Key Companies: Recent Developments: • In February 2025, IT Medical, a company renowned for its cutting-edge software solutions, created the Artificial Intelligence Diagnostics Assistant (AIDA) by utilizing OpenAl's Large Language Models (LLMs) and optimizing it with real-world patient interactions, medical language, and health protocols. AIDA can provide individualized, real-time help with precise, easily accessible data by interpreting patient inquiries, offering directions in plain language, and collecting system data. • In January 2025, Hurdle, a solution-oriented company, announced extensive global relationships and technological advancements with a focus on precision health and diagnostics for the year 2025. Over the last four years, the business has invested more than US$ 20 million in creating an Al-enabled diagnostics platform that will transform the field of biomarker discovery and diagnostics going forward. This investment demonstrates Hurdle's commitment to precision medicine innovation through the use of a platform that combines software-driven automation, multi-modal data, and Al-powered insights. U.S. Artificial Intelligence in Diagnostics Market Report Segmentation This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. For this study, Statifacts has segmented the global U.S. Artificial Intelligence in Diagnostics Market By Component Hardware Software Services By Diagnosis Type Radiology Pathology Cardiology Oncology Neurology Chest and Lung Others Immediate Delivery Available | Buy This Premium Databook ( Price USD 1550 ) Browse More Research Reports ; U.S. Lyme Disease Diagnostic Devices Market : The U.S. lyme disease diagnostic devices market size accounted for USD 750.20 million in 2024 and is expected to exceed around USD 1,318.36 million by 2034, growing at a CAGR of 5.8% from 2025 to 2034. U.S. Blood Pressure Monitoring Devices Market : The U.S. blood pressure monitoring devices market size accounted for USD 670.25 million in 2024 and is expected to exceed around USD 1,407.32 million by 2034, growing at a CAGR of 7.7% from 2025 to 2034. U.S. Population Health Management Market : The U.S. population health management market size accounted for USD 12,080 million in 2024 and is expected to exceed around USD 62,960 million by 2034, growing at a CAGR of 17.95% from 2025 to 2034. U.S. Smart Healthcare Market : The U.S. smart healthcare market size is calculated at USD 68.11 billion in 2024 and is predicted to reach around USD 250.94 billion by 2034, expanding at a CAGR of 13.93% from 2025 to 2034. U.S. Legal Marijuana Market : The U.S. legal marijuana market size accounted for USD 16,380 million in 2024 and is expected to exceed around USD 1,22,620 million by 2034, growing at a CAGR of 22.3% from 2025 to 2034. U.S. Medical Imaging Outsourcing Market : The U.S. medical imaging outsourcing market size is calculated at USD 14,160 million in 2024 and is predicted to attain around USD 21,780 million by 2034, expanding at a CAGR of 4.4% from 2025 to 2034. U.S. Pharmaceutical CDMO Market : The U.S. pharmaceutical CDMO market size accounted for USD 40,540 million in 2024 and is predicted to touch around USD 84,330 million by 2034, growing at a CAGR of 7.6% from 2025 to 2034. U.S. Integrated Delivery Network Market : The U.S. integrated delivery network market size surpassed USD 2,150 billion in 2024 and is predicted to reach around USD 5,730 billion by 2034, registering a CAGR of 10.3% from 2025 to 2034. Statifacts offers subscription services for data and analytics insights. This page provides options to explore and purchase a subscription tailored to your needs, granting access to valuable statistical resources and tools. Access here - USA: +1 804 441 9344 APAC: +61 485 981 310 or +91 87933 22019 Europe: +44 7383 092 044 Email: sales@ Web: Web : You can place an order or ask any questions, please feel free to contact at sales@ | +1 804 441 9344 About US In a world drowning in data, where every decision feels like a gamble, there's a place where clarity reigns supreme. A place where insights are not just found but created. Welcome to Statifacts, where we transform raw numbers into actionable strategies, and where every piece of data offers a deep dive into industry's insights. We believe in data with a heartbeat. Numbers should be more than just figures on a screen; they should pulse with the life of your market, echoing the trends, the shifts, the opportunities that are just around the corner. Our statistics are curated, crafted, and delivered in a way that speaks directly to you, helping you make sense of the noise and find the signal that matters. For Latest Update Follow Us: Statifacts | Precedence Research| Towards Healthcare Statifacts; Statifacts Business Industry News ; Statifacts US Business News ; Visit Our Sitemap ; in to access your portfolio
Yahoo
21-02-2025
- Business
- Yahoo
U.S. Gene Therapy Market Size, Share, Trends, Growth, & Analysis, Report
The U.S. gene therapy market size is calculated at USD 4,370 million in 2025 and is projected to hit around USD 22,230 million by 2034, growing at a compound annual growth rate (CAGR) of 19.8% over the forecast period 2025 to 2034 , the rapid investment by leading companies, the increased prevalence of chronic diseases, and the integration of advanced technology have driven the market demand. Ottawa , Feb. 21, 2025 (GLOBE NEWSWIRE) -- The U.S. gene therapy market size was valued at USD 3,650 million in 2024 and is expected to surpass around USD 22,230 million by 2034, growing at a compound annual growth rate (CAGR) of 19.8% over the forecast period 2025 to 2034, a study published by Statifacts a sister firm of Precedence Statistics. U.S. Gene Therapy Market Report Highlights Large B-cell lymphoma dominated the indication segment with the largest revenue share of 39.04% in 2024. This is attributed to the high prevalence of this type of cancer in the country. Additionally, gene therapy has shown promising results in treating this disease, leading to increased adoption by healthcare providers and patients. The intravenous route of administration held the larger market share in 2024 and is expected to grow at a higher CAGR during the forecast period. This route of administration involves the use of viruses, such as adenovirus, retrovirus, or lentivirus, to deliver the desired gene into the patient's cells. Based on vector type, the lentivirus segment dominated with the largest revenue share in 2024. On the other hand, AAV is anticipated to grow at the highest CAGR from 2025 to 2034, owing to the rising demand and their usage in clinical trials due to the higher accuracy level in delivering the gene to the region of interest. Elevate your business strategy with Statifacts. Improve efficiency and achieve better outcomes—schedule a consultation today! Gene therapy represents a groundbreaking approach to treating various illnesses by modifying, replacing, or supplementing defective or absent genes that contribute to disease onset. This innovative treatment has emerged as a focal point of research, particularly in the battle against degenerative diseases that afflict millions in the United States. The surge in cases of cancer and chronic illnesses has intensified the urgency for developing effective gene therapies. As a result, numerous advancements in these therapies are anticipated to gain regulatory approval in the near future, which is expected to significantly bolster the growth of the U.S. gene therapy market over the forecast period. The mechanisms of gene therapy are primarily centered around the manipulation of genetic material. Strategies include inactivating problematic genes that contribute to disease or replacing them with healthy copies capable of restoring normal function. This therapeutic approach has shown promise across a diverse range of disorders, revealing the potential to cure illnesses such as diabetes, various forms of cancer, cardiovascular diseases, and even HIV/AIDS. A number of factors facilitate the expansion of the U.S. gene therapy market. These include a robust portfolio of innovative products, increasing investments from leading industry stakeholders, and a high prevalence of diseases targeted by gene therapy. Additionally, there is growing interest in revolutionary therapeutic techniques. However, the path to widespread implementation is not without obstacles. The high costs associated with product development, coupled with stringent regulatory frameworks, pose significant challenges that may impede growth in the market. In developed nations, advanced therapeutic solutions are increasingly replacing traditional treatment modalities such as chemotherapy that often come with severe side effects and long-term health repercussions. This shift highlights the importance of emerging gene therapies, particularly those utilizing viral vectors known for their low toxicity levels and high immunological compatibility. Artificial intelligence (AI) plays a pivotal role in the evolution of gene therapy by analyzing extensive genomic and molecular datasets to pinpoint potential gene therapy targets and validate their therapeutic relevance. AI-driven tools facilitate the identification of novel gene candidates while assessing their stability and efficacy for therapeutic applications. Furthermore, AI can aid in crafting personalized treatment strategies, enabling healthcare providers to design tailored gene therapy interventions that are more likely to yield positive outcomes for individual patients. In addition, AI technologies support the real-time monitoring of patient data, allowing for adaptive therapy approaches based on gene expression profiles, clinical parameters, and individual treatment responses. This improvement in monitoring can significantly enhance the overall efficacy of gene therapies. Moreover, the introduction of AI in the manufacturing processes of saline gene therapy can lead to substantial advancements. By automating workflows, optimizing production yields, and ensuring rigorous quality control, AI can help decrease production costs, thus making these advanced therapies more accessible to patients who need them. The integration of AI into various stages of gene therapy development and production marks a significant leap toward effective, affordable, and personalized medical care, giving a significant boost to research and, in turn to demand in the U.S. gene therapy market. Immediate Delivery Available | Buy This Premium Databook ( Price USD 1550 ) U.S. Gene Therapy Market Report Scope Report Coverage Details Market Size in 2024 USD 3,650 Million Market Size in 2025 USD 4,370 Million Market Size by 2034 USD 22,230 Million Growth Rate from 2025 to 2034 CAGR of 19.8% Base Year 2024 Forecast Period 2025 to 2034 Segments Covered By Type, By Vector, By Therapeutic Area, By Delivery Method, and By Route of Administration U.S. Gene Therapy Market Trends • Emergence in Different Fields: While gene therapy initially concentrated on rare monogenic diseases, there is an increasing impetus to expand its application to more common conditions, including various forms of cancer, cardiovascular diseases, and neurological disorders such as Alzheimer's and Parkinson's. This shift is propelled by significant advancements in gene therapy technologies, coupled with a more profound understanding of the genetic underpinnings of complex diseases. Researchers are now focusing on the intricate interactions between multiple genes and environmental factors, thus broadening the scope of potential interventions.• Advancements in Gene Editing: CRISPR-Cas9 and other innovative gene editing technologies are transforming the landscape of gene therapy by allowing for precise modifications at the genomic level, whether through correction of deleterious mutations or targeted gene knockout. These cutting-edge tools are not only revolutionizing the treatment of hereditary genetic disorders, such as cystic fibrosis and sickle cell anemia but they are also being rigorously investigated in clinical trials for a wide range of applications, including viral infections and tumor suppressor genes in cancer therapy.• Enhanced Vector Engineering: In recent years, researchers have dedicated significant efforts to engineering viral vectors that feature heightened tissue specificity while minimizing off-target effects. This entails the meticulous modification of viral capsids to enhance their ability to target specific cell types, which is critical in reducing unintended immune responses. The development of these optimized vectors aims to lead to safer and more effective delivery mechanisms for gene therapies, ensuring that therapeutic genes are accurately delivered to the intended cells, thereby increasing the probability of treatment success.• Regulatory Approvals and Market Access: There has been a notable rise in the number of regulatory approvals granted for gene therapies, which is expanding patient access to these groundbreaking treatments. Regulatory agencies, recognizing the transformative potential of gene therapy, are actively working to streamline the approval processes. This includes providing clearer guidance for developers to navigate the regulatory landscape and fostering a more efficient pathway for bringing these innovative therapies to the U.S. gene therapy market, thus accelerating their availability to patients in need.• Combination Therapies: Researchers are also investigating the synergistic potential of combining gene therapies with other treatment modalities, such as immunotherapies and targeted pharmaceutical interventions. This integrative approach aims to enhance therapeutic efficacy and provide more comprehensive solutions for complex diseases. For instance, combining gene therapy with checkpoint inhibitors in cancer treatment could potentially activate the immune system to more effectively target and eliminate cancer cells, showcasing the promise of multidisciplinary strategies in modern medicine. Buy this Databook (Price USD1550) Market Segmentation Type Insights The gene silencing segment has established itself as the predominant force in the U.S. gene therapy market in 2024, capturing the largest share primarily due to its unparalleled precision in targeting specific genes implicated in various diseases. This segment is also the fastest-growing and anticipated to grow with the highest CAGR in the market during the studied years. By employing a gene silencing mechanism, this approach effectively diminishes the expression of detrimental genes, making it particularly suitable for treating a wide array of conditions, including multiple cancer types, genetic disorders such as cystic fibrosis, and viral infections like HIV. Additionally, the utilization of gene silencing techniques is increasingly becoming integral to the development of innovative therapeutics aimed at combating cancer and other serious health Insights In the realm of gene therapy, the viral vector segment has emerged as a leader in the U.S. market in 2024, thanks to its exceptional ability to accurately target specific cell types. Viral vectors are characterized by their high transduction rates, which facilitate the effective transfer of therapeutic genes into targeted host cells. The rising demand for these specialized delivery systems has further strengthened this market segment. Furthermore, viral vectors are noted for their efficiency in delivering genetic materials, which enhances their applicability in diverse gene therapy contexts. Conversely, the non-viral vector segment is anticipated to become increasingly opportunistic during the forthcoming forecast period 2025 to 2034. This expectation is attributed to the broad accessibility of non-viral vector gene therapies, which are often favored over their viral counterparts due to their simpler production processes and superior safety profiles. Moreover, non-viral vectors significantly mitigate the risks associated with insertional mutagenesis, thereby presenting a safer alternative for patients receiving gene therapy. Therapeutic Area Insights The oncology segment has firmly established itself as the leader in the U.S. gene therapy market in 2024, driven largely by the escalating incidence of cancer in the country. Gene therapies have gained considerable momentum in cancer treatment, owing to their capacity to specifically target cancerous cells while minimizing the adverse effects that are commonly associated with traditional chemotherapy. This targeted approach not only enhances treatment efficacy but also contributes to improved patient quality of life. The recent surge in the approval of gene therapies designed to treat cancer, alongside the rising incidence of hematologic tumors, has further propelled growth in this segment. The neurology segment is poised for rapid expansion in the coming years, fueled by the increasing prevalence of neurological disorders such as Alzheimer's disease and Parkinson's disease. Significant advancements in targeted gene therapy methodologies have opened new avenues for treating these complex conditions through various techniques, which range from exogenous gene expression to the suppression of endogenous genes. Delivery Method Insights The in vivo segment has asserted its dominance within the U.S. gene therapy market in 2024. This growth can be attributed to the in vivo method's efficacy in delivering genes directly into patients' bodies, thereby enhancing the overall effectiveness of therapeutic interventions. The in vivo approach is inherently less invasive than ex vivo methods, which often require complex surgical procedures to manipulate cells outside the body. As the demand for targeted therapies continues to rise, in vivo gene therapy has gained significant popularity, thereby driving the expansion of this segment within the market. The ex vivo segment of the U.S. gene therapy market is projected to expand rapidly in the market in the coming years due to a number of factors. Ex vivo gene therapy deals with the modification of patient cells outside the host body and then reintroducing them after specific genetic changes. These type of therapeutics offer long-lasting effects. Ex vivo treatment is particularly used for treating genetic disorders where a one-time intervention can significantly improve patient quality of life. Advancements in gene editing technologies such as CRISPR/Cas9 have caused a surge in ex vivo therapies. Route of Administration Insights Leading the charge in the U.S. gene therapy market, the intravenous (IV) segment has garnered attention due to its unique advantages over other routes of administration. Intravenous delivery allows for quicker absorption and immediate therapeutic effects since the therapeutic agents go directly into the bloodstream, bypassing the digestive system. This method is particularly advantageous as it facilitates the simultaneous treatment of multiple targeted organs, offering a comprehensive approach to patient care. The rapid delivery of gene therapy to targeted tissues, combined with its remarkable effectiveness, has been crucial in bolstering this segment. Innovations in vector design and advanced delivery mechanisms have led to the evolution of minimally invasive intravenous therapies, further contributing to the growth and appeal of this route of administration in the gene therapy landscape. Related Reports: • Cell and Gene Therapy Market: • U.S. Cell And Gene Therapy CDMO Market: • U.S. Cell and Gene Therapy Bioanalytical Testing Services Market: • Cell Therapy Growth Factor Market: • Cell Therapy Manufacturing Market: • Compression Therapy Markethttps:// • U.S. CRISPR and Cas Genes Markethttps:// • U.S. Gene Expression Markethttps:// U.S. Gene Therapy Market Top Key Companies: • Amgen Inc. • Novartis AG • F. Hoffmann-La Roche • Gilead Sciences, Inc. • bluebird bio, Inc. • Bristol-Myers Squibb Company • Legend Biotech. • BioMarin. • uniQure N.V. • Merck & Co. • Sarepta Therapeutics, Inc. • Krystal Biotech, Inc. • CRISPR Therapeutics. Recent Developments • In February 2025, gene therapy company AskBio Inc., a subsidiary of Bayer AG, announced that investigational genel therapy AB-1005 for the management and treatment of Parkinson's disease, has recieved the RMAT designation from the United States Food and Drug Administration (FDA). RMAT or Regenerative Medicine Advanced Therapy is a special designation granted by the FDA for medical treatments such as gene therapies, for the treatment, modificiation, reversal or cure of debilitating, and fatal conditions and diseases. • In April 2024, the President of India Droupadi Murmu launched the country's first home-grown anti-cancer CAR-T cell therapy at the Indian Institute of Technology, (IIT) Bombay in Mumbai. She also expressed that gene therapy will be a valuable asset for many patients U.S. Gene Therapy Market Report Segmentation This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. For this study, Statifacts has segmented the global U.S. Gene Therapy Market U.S. Gene Therapy Market Segmentation: By Type Gene silencing Cell replacement Gene augmentation Other therapies By Vector Viral vectors Non-Viral vectors By Therapeutic Area Neurology Oncology Hepatology Other therapeutic areas By Delivery Method In Vivo Ex Vivo By Route of Administration Intravenous Other routes of administration Immediate Delivery Available | Buy This Premium Databook ( Price USD 1550 ) Statifacts offers subscription services for data and analytics insights. This page provides options to explore and purchase a subscription tailored to your needs, granting access to valuable statistical resources and tools. Access here - USA: +1 804 441 9344 APAC: +61 485 981 310 or +91 87933 22019 Europe: +44 7383 092 044 Email: sales@ Web: Web : You can place an order or ask any questions, please feel free to contact at sales@ | +1 804 441 9344 About US In a world drowning in data, where every decision feels like a gamble, there's a place where clarity reigns supreme. A place where insights are not just found but created. Welcome to Statifacts, where we transform raw numbers into actionable strategies, and where every piece of data offers a deep dive into industry's insights. We believe in data with a heartbeat. Numbers should be more than just figures on a screen; they should pulse with the life of your market, echoing the trends, the shifts, the opportunities that are just around the corner. Our statistics are curated, crafted, and delivered in a way that speaks directly to you, helping you make sense of the noise and find the signal that matters. For Latest Update Follow Us: Statifacts | Precedence Research| Towards HealthcareSign in to access your portfolio
